Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours Β· Estimated delivery Sep 1 - Sep 6
Gastrointestinal side effects affect up to 60% of patients starting GLP-1 receptor agonists like semaglutide, with nausea and abdominal discomfort ranking among the most common complaints
Incretin mimetics are a relatively new group of injectable drugs for treatment of type 2 diabetes and obesity
doi:10.1056/nejm196505132721901
Comparing semaglutide to other medications commonly injected incorrectly Semaglutide is not unique in being accidentally injected into the wrong tissue layer
[PMID: 11036647] PubMed record related to this compound for laboratory literature review
US$ 25.63
US$ 25.01
US$ 28.57
